NCT01313078: Phase II Study of Clinical Activity of Pegaspargase in Women With Relapsed or Refractory Epithelial Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer |
|
|
| Completed | 2 | 4 | US | Pegylated L-Asparaginase, Oncaspar | National Cancer Institute (NCI) | Ovarian Neoplasms, Fallopian Tube Neoplasms, Primary Peritoneal Neoplasms | 09/11 | 09/11 | | |
